Hu, W.;                     Zhang, L.;                     Ferri-Borgogno, S.;                     Kwan, S.-Y.;                     Lewis, K.E.;                     Cun, H.T.;                     Yeung, T.-L.;                     Soliman, P.T.;                     Tarapore, R.S.;                     Allen, J.E.;     
    et al.    Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436.
    https://doi.org/10.3390/cancers12092436
    AMA Style
    
                                Hu W,                                 Zhang L,                                 Ferri-Borgogno S,                                 Kwan S-Y,                                 Lewis KE,                                 Cun HT,                                 Yeung T-L,                                 Soliman PT,                                 Tarapore RS,                                 Allen JE,         
        et al.        Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers. 2020; 12(9):2436.
        https://doi.org/10.3390/cancers12092436
    
    Chicago/Turabian Style
    
                                Hu, Wen,                                 Li Zhang,                                 Sammy Ferri-Borgogno,                                 Suet-Ying Kwan,                                 Kelsey E. Lewis,                                 Han T. Cun,                                 Tsz-Lun Yeung,                                 Pamela T. Soliman,                                 Rohinton S. Tarapore,                                 Joshua E. Allen,         
         and et al.        2020. "Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype" Cancers 12, no. 9: 2436.
        https://doi.org/10.3390/cancers12092436
    
    APA Style
    
                                Hu, W.,                                 Zhang, L.,                                 Ferri-Borgogno, S.,                                 Kwan, S.-Y.,                                 Lewis, K. E.,                                 Cun, H. T.,                                 Yeung, T.-L.,                                 Soliman, P. T.,                                 Tarapore, R. S.,                                 Allen, J. E.,                                 Guan, X.,                                 Lu, K. H.,                                 Mok, S. C.,                                 & Au-Yeung, C.-L.        
        
        (2020). Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers, 12(9), 2436.
        https://doi.org/10.3390/cancers12092436